title: New generation antiepileptic drugs: what do they offer in terms of improved tolerability and safety?
abstract: Over the last two decades a total of 11 antiepileptic drugs (AEDs) have been introduced to the US market. Randomized, placebo-controlled trials have yielded information about each drug's efficacy, tolerability, and safety profile; however, few studies have compared the newer generation AEDs directly with the older generation. Comparative studies are not always straightforward in their interpretation, as many characteristics of drugs, both favorable and unfavorable, may not be highlighted by such studies. In general, findings from the literature suggest that the newer generation AEDs (including vigabatrin, felbamate, gabapentin, lamotrigine, tiagabine, topiramate, levetiracetam, oxcarbazepine, zonisamide, pregabalin, rufinamide, and lacosamide) enjoy both improved tolerability and safety compared with older agents such as phenobarbital, phenytoin, carbamazepine, and valproate. This is partially supported by some of the findings of the QSS and the TTA Committee of the American Academy of Neurology (AAN), whose review of four AEDs (gabapentin, lamotrigine, topiramate, and tiagabine) is discussed. Briefly, when compared with carbamazepine, lamotrigine was better tolerated; topiramate adverse events (AEs) were fairly comparable to carbamazepine and valproate; and tiagabine compared with placebo was associated with a higher discontinuation rate due to AEs. The findings of the SANAD trial are also presented; when administered to patients with partial epilepsy, carbamazepine was most likely to fail due to AEs, and lamotrigine and gabapentin were least likely to fail due to AEs. When administered to patients with idiopathic generalized epilepsy, topiramate was most frequently associated with AE-related discontinuation, followed by valproate; and while valproate was the most efficacious drug in this arm of the study, lamotrigine was more tolerable. What makes the SANAD study valuable and somewhat unique is its head-to-head comparison of one drug with another. Such comparative trials are overall lacking for new AEDs, although some conclusions can be drawn from the available data. In the end, however, AED selection must be based on individual patient and drug characteristics.
authors.affiliation: New York University School of Medicine, NYU Comprehensive Epilepsy Center, 223 East 34th Street, New York, NY 10016, USA.
authors.forename: Jacqueline A
authors.initials: JA
authors.lastname: French
authors.affiliation: New York University School of Medicine, NYU Comprehensive Epilepsy Center, New York, NY, USA.
authors.forename: Deana M
authors.initials: DM
authors.lastname: Gazzola
keywords: SANAD; adverse event; antiepileptic drug; safety; tolerability; toxicity
references.citation: Am J Psychiatry. 1995 Mar;152(3):413-8
references.pmid: 7864268
references.citation: Neurology. 1991 Nov;41(11):1785-9
references.pmid: 1944909
references.citation: Seizure. 2000 Mar;9(2):80-7
references.pmid: 10845730
references.citation: Epilepsia. 2005 Feb;46(2):320-3
references.pmid: 15679514
references.citation: Drugs. 1994 Feb;47(2):332-72
references.pmid: 7512905
references.citation: Epilepsia. 2005 Jan;46(1):31-41
references.pmid: 15660766
references.citation: Drug Saf. 1999 Sep;21(3):225-39
references.pmid: 10487399
references.citation: Epilepsy Res. 1997 Jun;27(3):195-204
references.pmid: 9237054
references.citation: Ther Adv Neurol Disord. 2010 Mar;3(2):77-83
references.pmid: 21179600
references.citation: Science. 1937 May 28;85(2213):525-6
references.pmid: 17750072
references.citation: N Engl J Med. 2010 Mar 4;362(9):790-9
references.pmid: 20200383
references.citation: Pediatrics. 1978 May;61(5):728-31
references.pmid: 662511
references.citation: Acta Neurol Scand. 2003 Mar;107(3):165-75
references.pmid: 12614309
references.citation: Expert Opin Drug Metab Toxicol. 2008 Apr;4(4):493-506
references.pmid: 18433351
references.citation: Epilepsy Res. 1989 Jan-Feb;3(1):70-6
references.pmid: 2645120
references.citation: Epilepsy Res. 1998 Mar;30(1):31-40
references.pmid: 9551842
references.citation: J Child Neurol. 2009 Dec;24(12):1520-5
references.pmid: 19955344
references.citation: Epilepsy Res. 2010 Jan;88(1):46-54
references.pmid: 19914041
references.citation: Ther Drug Monit. 2002 Feb;24(1):74-80
references.pmid: 11805726
references.citation: J Bone Miner Res. 2010 Apr;25(4):873-81
references.pmid: 19839772
references.citation: Health Technol Assess. 2007 Oct;11(37):iii-iv, ix-x, 1-134
references.pmid: 17903391
references.citation: Epilepsia. 1998 Jun;39(6):671-4
references.pmid: 9637612
references.citation: Epilepsia. 2009 May;50(5):978-86
references.pmid: 19496806
references.citation: Arch Neurol. 1998 Jan;55(1):56-62
references.pmid: 9443711
references.citation: Expert Rev Neurother. 2008 Jul;8(7):1013-24
references.pmid: 18590472
references.citation: Epilepsia. 1987;28 Suppl 3:S64-70
references.pmid: 2961558
references.citation: Epilepsia. 1991 Jul-Aug;32(4):539-42
references.pmid: 1907907
references.citation: Epilepsy Res. 2007 Jul;75(2-3):75-83
references.pmid: 17553670
references.citation: Epileptic Disord. 2001 Jun;3(2):91-100
references.pmid: 11431171
references.citation: Arch Neurol. 1997 May;54(5):595-601
references.pmid: 9152116
references.citation: Epilepsia. 1994 Jul-Aug;35(4):795-801
references.pmid: 8082624
references.citation: CNS Drugs. 2011 Feb;25(2):89-107
references.pmid: 21254787
references.citation: Neurology. 1998 Nov;51(5):1282-8
references.pmid: 9818846
references.citation: Epilepsy Res. 1993 May;15(1):67-73
references.pmid: 8325280
references.citation: Epilepsia. 1996;37 Suppl 2:S18-S22
references.pmid: 8641242
references.citation: Epilepsy Res. 2000 Dec;42(2-3):123-32
references.pmid: 11074185
references.citation: Neurology. 2007 Feb 6;68(6):402-8
references.pmid: 17283312
references.citation: Epilepsia. 2000 Sep;41(9):1179-86
references.pmid: 10999557
references.citation: Epilepsy Res. 1997 Mar;26(3):451-60
references.pmid: 9127726
references.citation: Cochrane Database Syst Rev. 2011 Jan 19;(1):CD008295
references.pmid: 21249704
references.citation: N Engl J Med. 1985 Jul 18;313(3):145-51
references.pmid: 3925335
references.citation: Lancet. 1990 May 12;335(8698):1114-7
references.pmid: 1971862
references.citation: Int Rev Neurobiol. 2008;83:305-28
references.pmid: 18929090
references.citation: Med Princ Pract. 2005 Jan-Feb;14(1):31-4
references.pmid: 15608478
references.citation: Neuropsychiatr Dis Treat. 2009;5:249-59
references.pmid: 19557119
references.citation: Epilepsy Res. 2000 Aug;41(1):23-8
references.pmid: 10924865
references.citation: AMA Am J Dis Child. 1953 Dec;86(6):717-25
references.pmid: 13103793
references.citation: Epilepsia. 2007 Jul;48(7):1292-302
references.pmid: 17561956
references.citation: Expert Opin Pharmacother. 2008 Feb;9(2):285-92
references.pmid: 18201150
references.citation: Clin Neuropharmacol. 2005 Mar-Apr;28(2):72-8
references.pmid: 15795549
references.citation: Neurology. 2003 May 27;60(10):1631-7
references.pmid: 12771254
references.citation: Epilepsy Res. 1997 Jun;27(3):205-13
references.pmid: 9237055
references.citation: Mol Pharmacol. 2000 Aug;58(2):253-62
references.pmid: 10908292
references.citation: Neurology. 2008 Aug 26;71(9):665-9
references.pmid: 18725591
references.citation: CNS Drug Rev. 2007 Summer;13(2):224-39
references.pmid: 17627674
references.citation: Epilepsia. 2000 Oct;41(10):1276-83
references.pmid: 11051122
references.citation: Pediatr Neurol. 1999 Aug;21(2):523-8
references.pmid: 10465137
references.citation: Neurology. 2005 Jun 14;64(11):1868-73
references.pmid: 15955935
references.citation: Epilepsia. 2009 May;50(5):1237-46
references.pmid: 19507301
references.citation: Epilepsy Res. 1999 Oct;37(1):81-7
references.pmid: 10515178
references.citation: Rev Pathol Gen Physiol Clin. 1962 Jan;62:107-11
references.pmid: 13881190
references.citation: Neurology. 2009 Mar 17;72(11):987-91
references.pmid: 19289738
references.citation: Neurology. 2011 Jan 11;76(2):131-7
references.pmid: 21148119
references.citation: Epilepsia. 1991 May-Jun;32(3):392-7
references.pmid: 2044501
references.citation: Epilepsia. 1999 May;40(5):601-7
references.pmid: 10386529
references.citation: Neurology. 2010 Aug 10;75(6):519-25
references.pmid: 20592253
references.citation: Epilepsy Res. 2008 Sep;81(1):1-13
references.pmid: 18565732
references.citation: Lancet Neurol. 2004 Oct;3(10):618-21
references.pmid: 15380158
references.citation: Curr Opin Neurol. 2010 Apr;23(2):164-9
references.pmid: 20125012
references.citation: Epilepsia. 1978 Aug;19(4):393-408
references.pmid: 359324
references.citation: Neurology. 1993 Nov;43(11):2292-8
references.pmid: 8232945
references.citation: Seizure. 2009 Apr;18(3):184-92
references.pmid: 18951818
references.citation: Epileptic Disord. 2003 Sep;5(3):157-9
references.pmid: 14684351
references.citation: CNS Drugs. 2010 Dec;24(12):1041-54
references.pmid: 21090838
references.citation: Epilepsia. 2009 Mar;50(3):454-63
references.pmid: 19243424
references.citation: Epilepsia. 1997 Dec;38(12):1265-9
references.pmid: 9578520
references.citation: Neurology. 2000 Jul 25;55(2):236-42
references.pmid: 10908898
references.citation: J Clin Pharmacol. 2004 Aug;44(8):906-18
references.pmid: 15286095
references.citation: Arch Neurol. 2000 Dec;57(12):1782-5
references.pmid: 11115250
references.citation: Epilepsy Res. 1995 May;21(1):37-42
references.pmid: 7641674
references.citation: Epilepsia. 2005 Oct;46(10):1625-32
references.pmid: 16190934
references.citation: Neurology. 2010 Nov 16;75(20):1817-24
references.pmid: 20944074
references.citation: Acta Neurol Scand. 2008 Nov;118(5):281-90
references.pmid: 18341684
references.citation: Neurology. 1993 Apr;43(4):693-6
references.pmid: 8469324
references.citation: Lancet. 1995 Feb 25;345(8948):476-9
references.pmid: 7710545
references.citation: Seizure. 2000 Apr;9(3):224-32
references.pmid: 10777431
references.citation: Neurology. 2001 Nov 27;57(10):1774-9
references.pmid: 11723262
references.citation: Seizure. 2003 Apr;12(3):131-5
references.pmid: 12651076
references.citation: J Clin Pharmacol. 2003 May;43(5):491-503
references.pmid: 12751270
references.citation: Int J Neurol. 1978;11(4):383-400
references.pmid: 94596
references.citation: J Neurol Neurosurg Psychiatry. 2006 Feb;77(2):193-8
references.pmid: 16157661
references.citation: Epilepsia. 2004 May;45(5):401-9
references.pmid: 15101821
references.citation: Epilepsia. 2009 Mar;50 Suppl 3:69-92
references.pmid: 19298434
references.citation: BMJ. 2010 Dec 02;341:c6582
references.pmid: 21127117
references.citation: Epilepsia. 2000;41 Suppl 8:S37-44
references.pmid: 11092611
references.citation: Epilepsy Behav. 2010 Apr;17(4):546-8
references.pmid: 20185372
references.citation: Neurology. 2005 Dec 27;65(12):1976-8
references.pmid: 16380624
references.citation: Arch Neurol. 1999 May;56(5):605-7
references.pmid: 10328256
references.citation: Neurology. 2005 Apr 12;64(7):1134-8
references.pmid: 15824335